AI-generated sensors open new paths for early cancer detection
Published in Artificial Intelligence, Diseases!, Nanomedicine.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat when caught early. To help achieve that goal, MIT and Microsoft researchers are using artificial intelligence to design molecular sensors for early detection.
The researchers developed an AI model to design peptides (short proteins) that are targeted by enzymes called proteases, which are overactive in cancer cells. Nanoparticles coated with these peptides can act as sensors that give off a signal if cancer-linked proteases are present anywhere in the body.
Depending on which proteases are detected, doctors would be able to diagnose the particular type of cancer that is present. These signals could be detected using a simple urine test that could even be done at home.
“We’re focused on ultra-sensitive detection in diseases like the early stages of cancer, when the tumor burden is small, or early on in recurrence after surgery,” says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science at MIT, and a member of MIT’s Koch Institute for Integrative Cancer Research and the Institute for Medical Engineering and Science (IMES).
Bhatia and Ava Amini ’16, a principal researcher at Microsoft Research and a former graduate student in Bhatia’s lab, are the senior authors of the study, which appears today in Nature Communications. Carmen Martin-Alonso PhD ’23, a founding scientist at Amplifyer Bio, and Sarah Alamdari, a senior applied scientist at Microsoft Research, are the paper’s lead authors.
Amplifying cancer signals
More than a decade ago, Bhatia’s lab came up with the idea of using protease activity as a marker of early cancer. The human genome encodes about 600 proteases, which are enzymes that can cut through other proteins, including structural proteins such as collagen. They are often overactive in cancer cells, as they help the cells escape their original locations by cutting through proteins of the extracellular matrix, which normally holds cells in place.
The researchers’ idea was to coat nanoparticles with peptides that can be cleaved by a specific protease. These particles could then be ingested or inhaled. As they traveled through the body, if they encountered any cancer-linked proteases, the peptides on the particles would be cleaved.
Those peptides would be secreted in the urine, where they could be detected using a paper strip similar to a pregnancy test strip. Measuring those signals would reveal the overactivity of proteases deep within the body.
https://news.mit.edu/2026/ai-generated-sensors-open-new-paths-early-cancer-detection-0106